Sustained Benefit of 6-Month Topiramate Treatment for Migraine
The effects of discontinuing topiramate after a treatment period of 6 months in 818 patients with migraine, enrolled from 88 clinics in 21 countries in Europe, the UK and Turkey, are reported from University Duisburg-Essen, Germany.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
2007-12-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/964 |